Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Aghazadeh Behzad
Director at Scribe Therapeutics. Filing since 24 Jul 2026.
CIK 0001701815
Company
Date
Role
Action
Shares
Amount
Of holding
SCTX
Scribe Therapeutics, Inc.
28 Jul 2026
Director
Bought
7,905
$144.27K
0.3%
SCTX
Scribe Therapeutics, Inc.
24 Jul 2026
Director
Bought
2,383,333
$36.12M
342%
2 decisions on file.
